Atlas Arteria

ALX

Atlas Arteria Ltd. owns, operates, and develops toll roads globally. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-01-25. The firm has a portfolio of five toll roads in France, Germany, and the United States. The firm owns a 31.14% interest in the Autoroutes Paris-Rhin-Rhone (APRR) toll road group in France. In addition to the APRR business is the smaller Autoroute des deux lacs (ADELAC) business, which connects to APRR in southeast France. Together APRR and ADELAC comprise approximately 2,424 kilometers of motorway network located in the East and Southeast of France. In the United States, it owns a 66.67% interest in the Chicago Skyway, a 12.5 kilometers toll road in Chicago and has 100% of the economic interest in the Dulles Greenway, a 22 kilometers toll road in the Commonwealth of Virginia. In Germany, it owns 100% of the Warnow Tunnel in the northeast city of Rostock.

Aurizon Holdings Limited

AZJ

Aurizon Holdings Ltd. is a rail freight operator, which engages in provision of customers with integrated freight and logistics solutions across an extensive national rail and road network, traversing Australia. The company is headquartered in Fortitude Valley, Queensland and currently employs 5,718 full-time employees. The company went IPO on 2010-11-22. The Company’s segments include Network, Coal and Bulk. The Network segment manages the provision of access to the CQCN rail infrastructure and operation and maintenance of the network. The Coal segment provides transport of metallurgical and thermal coal from mines in Queensland and New South Wales to domestic customers and coal export terminals. The Bulk segment provides integrated supply chain services, including rail and road transportation, port services and material handling for a range of mining, metal, industrial and agricultural customers throughout Australia. This segment also manages the Tarcoola-to-Darwin rail infrastructure, and the intrastate rail freight network in South Australia, and containerized freight services between Adelaide and Darwin. The company transports more than 250 million tons of Australian commodities, connecting miners, primary producers and industry with international and domestic markets.

Clinuvel Pharmaceuticals Limited

CUV

Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2001-02-13. The firm is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).

Sonic Healthcare Limited

SHL

Sonic Healthcare Ltd. engages in the provision of medical diagnostics services. The company is headquartered in Sydney, New South Wales and currently employs 41,000 full-time employees. The firm is engaged in laboratory medicine / pathology, radiology, and primary care medical services, across operations in Australia, Europe, and North America. The firm operates through three segments: Laboratory, Radiology and Other. The Laboratory segment provides pathology/clinical laboratory services in Australia, New Zealand, the United Kingdom, the United States of America, Germany, Switzerland, and Belgium. The Radiology segment provides diagnostic imaging services in Australia. The Radiology technologies include Magnetic resonance imaging (MRI), Computed tomography (CT), Ultrasound, X-ray, Mammography, and others. The Other segment includes medical center operations (IPN), occupational health services (Sonic HealthPlus), and other minor operations. The firm's provides services to clinicians, hospitals, community health services, and their patients. The firm has more than 120 radiology centers.

Tyro Payments Limited

TYR

Tyro Payments Ltd. engages in the provision of merchant credit, debit and EFTPOS acquisition services. The company is headquartered in Sydney, New South Wales and currently employs 647 full-time employees. The company went IPO on 2019-12-06. The firm is focused on providing Australian businesses with payment solutions and complementary business banking products. The firm provides credit, debit and electronic funds transfer at point of sale (EFTPOS) card acquiring, Medicare and private health fund claiming and rebating services to Australian businesses. The company takes money on deposit and offers unsecured cash-flow based lending to Australian EFTPOS merchants. The firm is focused on in-store payments through e-Commerce solutions. The company also provides solutions, such as its loans in the form of merchant cash advances and its fee-free, interest-bearing merchant transaction accounts and term-deposit accounts. The company offers Tyro Connect, which is an integration hub for applications and point of sale (POS) systems, a plug and play platform software solution. Its segments include Payments and Banking.